Clinical Trial Update: Vortioxetine for the Treatment of Mood and Cognitive Symptoms in Frontotemporal Dementia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating vortioxetine for mood and cognitive symptoms in frontotemporal dementia. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Drugs mentioned

• Vortioxetine (vortioxetine)

Snippet

Sponsor: Johns Hopkins University | Conditions: Fronto-temporal Dementia, Fronto-temporal Lobar Dementia | Phase 2 | Status: RECRUITING